International Patent: CD23-TARGETING COMPOSITIONS AND USES THEREOF FOR IMPROVED IMMUNOTHERAPIES

GENEVA, Aug. 31 -- AJAYA BIO, INC. filed a patent application (US2026/015720) for “CD23-TARGETING COMPOSITIONS AND USES THEREOF FOR IMPROVED IMMUNOTHERAPIES”. With publication no. WO/2026/178163, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/28

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....